Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study

by Minna Räsänen, Laura Renkonen-Sinisalo, Harri Mustonen, Anna Lepistö
Published 2019-08-01

Toll-like receptor 1 predicts favorable prognosis in pancreatic cancer.

by Mira Lanki, Hanna Seppänen, Harri Mustonen, Jaana Hagström, Caj Haglund
Published 2019-01-01

Mucin 16 and kallikrein 13 as potential prognostic factors in colon cancer: Results of an oncological 92-multiplex immunoassay

by Kajsa Björkman, Harri Mustonen, Tuomas Kaprio, Caj Haglund, Camilla Böckelman
Published 2019-07-01

The prognostic significance of tall cells in papillary thyroid carcinoma: A case-control study

by Sebastian Stenman, Päivi Siironen, Harri Mustonen, Johan Lundin, Caj Haglund, Johanna Arola
Published 2018-07-01

REG4 independently predicts better prognosis in non-mucinous colorectal cancer.

by Tuomas Kaprio, Jaana Hagström, Harri Mustonen, Selja Koskensalo, Leif C Andersson, Caj Haglund
Published 2014-01-01

UCHL5 expression associates with improved survival in lymph-node-positive rectal cancer

by Leena Arpalahti, Jaana Hagström, Harri Mustonen, Mikael Lundin, Caj Haglund, Carina I Holmberg
Published 2017-07-01

Impact of histological response after neoadjuvant therapy on podocalyxin as a prognostic marker in pancreatic cancer

by Annika Eurola, Ari Ristimäki, Harri Mustonen, Anna-Maria Nurmi, Jaana Hagström, Caj Haglund, Hanna Seppänen
Published 2021-05-01

Ornithine decarboxylase antizyme inhibitor 2 (AZIN2) is a signature of secretory phenotype and independent predictor of adverse prognosis in colorectal cancer.

by Tuomas Kaprio, Tiina Rasila, Jaana Hagström, Harri Mustonen, Petri Lankila, Caj Haglund, Leif C Andersson
Published 2019-01-01

Systemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal Adenocarcinoma.

by Aino Salmiheimo, Harri Mustonen, Ulf-Håkan Stenman, Pauli Puolakkainen, Esko Kemppainen, Hanna Seppänen, Caj Haglund
Published 2016-01-01

Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma

by Leena Arpalahti, Kapo Saukkonen, Jaana Hagström, Harri Mustonen, Hanna Seppänen, Caj Haglund, Carina I Holmberg
Published 2017-06-01

N-glycomic profiling of colorectal cancer according to tumor stage and location.

by Matilda Holm, Pirjo Nummela, Annamari Heiskanen, Tero Satomaa, Tuomas Kaprio, Harri Mustonen, Ari Ristimäki, Caj Haglund
Published 2020-01-01

Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome

by Matilda Holm, Sakari Joenväärä, Mayank Saraswat, Harri Mustonen, Tiialotta Tohmola, Ari Ristimäki, Risto Renkonen, Caj Haglund
Published 2019-12-01

PD-1 and PD-L1 expression in pulmonary carcinoid tumors and their association to tumor spread

by Tiina Vesterinen, Teijo Kuopio, Maarit Ahtiainen, Aija Knuuttila, Harri Mustonen, Kaisa Salmenkivi, Johanna Arola, Caj Haglund
Published 2019-08-01

Serum MMP-8 and TIMP-1 as prognostic biomarkers in gastric cancer

by Alli Laitinen, Jaana Hagström, Harri Mustonen, Arto Kokkola, Taina Tervahartiala, Timo Sorsa, Camilla Böckelman, Caj Haglund
Published 2018-09-01

Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis.

by Leena Arpalahti, Alli Laitinen, Jaana Hagström, Harri Mustonen, Arto Kokkola, Camilla Böckelman, Caj Haglund, Carina I Holmberg
Published 2018-01-01

Prognostic and diagnostic value of REG4 serum and tissue expression in pancreatic ductal adenocarcinoma

by Kapo Saukkonen, Jaana Hagström, Harri Mustonen, Laura Lehtinen, Olli Carpen, Leif C Andersson, Hanna Seppänen, Caj Haglund
Published 2018-03-01

A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel

by Kajsa Björkman, Sirpa Jalkanen, Marko Salmi, Harri Mustonen, Tuomas Kaprio, Henna Kekki, Kim Pettersson, Camilla Böckelman, Caj Haglund
Published 2021-02-01

Podocalyxin Is a Marker of Poor Prognosis in Pancreatic Ductal Adenocarcinoma.

by Kapo Saukkonen, Jaana Hagström, Harri Mustonen, Anne Juuti, Stig Nordling, Christian Fermér, Olle Nilsson, Hanna Seppänen, Caj Haglund
Published 2015-01-01

Elevated tumor expression of Astroprincin (FAM171A1) is an independent marker of poor prognosis in colon cancer

by Tuomas Kaprio, Alexander M. Lindström, Tiina Rasila, Olga Saavalainen, Ines Beilmann-Lehtonen, Harri Mustonen, Caj Haglund, Leif C. Andersson
Published 2021-09-01

The Prognostic Importance of CD20+ B lymphocytes in Colorectal Cancer and the Relation to Other Immune Cell subsets

by Sofia Edin, Tuomas Kaprio, Jaana Hagström, Pär Larsson, Harri Mustonen, Camilla Böckelman, Karin Strigård, Ulf Gunnarsson, Caj Haglund, Richard Palmqvist
Published 2019-12-01